- Trials with a EudraCT protocol (15)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
15 result(s) found for: Aerobic exercise.
Displaying page 1 of 1.
EudraCT Number: 2009-016874-34 | Sponsor Protocol Number: PicoPEX-2009-16.10.2009 | Start Date*: 2010-02-22 |
Sponsor Name:Plymouth Hospitals NHS Trust | ||
Full Title: A Study into the Effect of Mechanical Bowel Preparation on Aerobic Exercise Capacity as Measured by Cardiopulmonary Exercise Testing. | ||
Medical condition: We are investigating the effect of mechanical bowel preparation, such as Picolax, on aerobic exercise capacity in healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-004533-21 | Sponsor Protocol Number: 03602 | Start Date*: 2010-06-25 | |||||||||||
Sponsor Name:ICIN | |||||||||||||
Full Title: The role of Bosentan in fontan patients: improvement of aerobic capacity | |||||||||||||
Medical condition: To study whether bosentan (endothelin receptor inhibitor) improves aerobic capacity (VO2max) and exercise performance in adult patients with a Fontan operation. | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002804-42 | Sponsor Protocol Number: Beta2-Mikro | Start Date*: 2012-09-10 |
Sponsor Name:Bispebjerg Hospital | ||
Full Title: The effects of high dose beta2-agonists on physical performance in healthy male subjects | ||
Medical condition: No medical condition will be investigated. To examine the effects of beta2-agonists on aerobic and anaerobic exercise performance. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: Removed from public view |
EudraCT Number: 2007-000319-27 | Sponsor Protocol Number: ALT-711-0527 | Start Date*: 2007-07-02 | |||||||||||
Sponsor Name:Alteon, Inc. | |||||||||||||
Full Title: A Double-blind, Placebo-Controlled, Randomized Trial Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients with Chronic Heart Failure | |||||||||||||
Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000462-62 | Sponsor Protocol Number: Statex1 | Start Date*: 2015-09-23 |
Sponsor Name:Radboud university medical centre | ||
Full Title: The effects of statins on skeletal muscle mitochondria: is exercise the medicine? | ||
Medical condition: Asymp and symp statin users will undergo baseline measurements of skeletal muscle mitochondrial function and muscle function after which they will be switched to a single-blind placebo intervention... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003231-46 | Sponsor Protocol Number: 0001 | Start Date*: 2005-11-04 |
Sponsor Name:Dept of Internal Medicine IV, Med Uni Vienna | ||
Full Title: Changes in hepatic lipid content assessed by MR Spectroscopy in patients with non-alcoholic fatty liver disease (NAFLD) under standard therapy (reduction diet and regular aerobic exercise) with and... | ||
Medical condition: Nonalcoholic fatty liver disease (NAFLD) is a potentially progressive liver disease, leading to cirrhosis in up to 26% of affected patients and rarely hepatocellular carcinoma. Several studies have... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-000483-29 | Sponsor Protocol Number: Wada_2012 | Start Date*: 2013-07-17 | |||||||||||
Sponsor Name:Bispebjerg Hospital | |||||||||||||
Full Title: The influence of exercise and hydration to the pharmacological response to inhaled terbutalin and salbutamol in men | |||||||||||||
Medical condition: To investigate the pharmacokinetic effect of the medicine under physical work in healthy men | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005592-13 | Sponsor Protocol Number: FERRICHFII | Start Date*: 2014-02-27 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Mechanisms of Exercise Benefit with Intravenous Iron in Chronic Heart Failure: The Ferric Iron in Heart Failure (FERRIC HF) II Trial | |||||||||||||
Medical condition: Chronic Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000054-28 | Sponsor Protocol Number: OLIGOTREAT | Start Date*: 2023-06-02 | |||||||||||
Sponsor Name:Klinikum der Universität München | |||||||||||||
Full Title: Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (OligoTreat) | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002969-38 | Sponsor Protocol Number: CFTY720DDE07 | Start Date*: 2011-11-08 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A 6-month, multicenter, randomized, controlled parallel group study to evaluate the effect of physical training on fatigue in patients with relapsing-remitting multiple sclerosis treated with fingo... | |||||||||||||
Medical condition: Fatigue in Patients with relapsing remitting Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004993-68 | Sponsor Protocol Number: 85256 | Start Date*: 2022-04-28 | |||||||||||
Sponsor Name:Steno Diabetes Center Copenhagen | |||||||||||||
Full Title: The HYPO-AVOID STUDY: Low-dose Glucagon and Advanced Hybrid Closed-loop System for Prevention of Exercise-Induced Hypoglycaemia in People with Type 1 Diabetes | |||||||||||||
Medical condition: Type 1 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004586-41 | Sponsor Protocol Number: UOL0753 | Start Date*: 2020-06-01 | |||||||||||
Sponsor Name:University of Leicester | |||||||||||||
Full Title: Impact of exercise training in combination with dapagliflozin on physical function in adults with type 2 diabetes mellitus: A Randomised controlled trial | |||||||||||||
Medical condition: Frailty and the preceding 'pre-frail' state in patients with type 2 Diabetes Mellitus. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003772-39 | Sponsor Protocol Number: DEMAND-pilot | Start Date*: 2019-12-13 |
Sponsor Name:Umeå University | ||
Full Title: Diet, physical exercise, and metabolic control intervention to reduce the incidence of major neurocognitive disorders among individuals with type 2 diabetes combined with mild neurocognitive impair... | ||
Medical condition: Type 2 diabetes | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2020-005745-16 | Sponsor Protocol Number: 77119 | Start Date*: 2021-03-22 | |||||||||||
Sponsor Name:Steno Diabetes Center Copenhagen | |||||||||||||
Full Title: Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People with Type 1 Diabetes: A Randomized, Open-Label, Two-Period Crossover Outpatient Study | |||||||||||||
Medical condition: Type 1 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000508-24 | Sponsor Protocol Number: 7406 | Start Date*: 2015-06-12 | |||||||||||
Sponsor Name:Newcastle Upon Tyne Hospitals NHS Trust | |||||||||||||
Full Title: A Feasibility Study of Bezafibrate in Mitochondrial Myopathy | |||||||||||||
Medical condition: Mitochondrial myopathy due to mt.3243A>G mutation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
